More Risk Management Articles

Pharmaceuticals

As Opioid Suits Loom, Now’s the Time to Act on D&O Insurance

Coverage for opioid exposures remains relatively untested, with existing case law increasing the uncertainty.

Litigation related to to the opioid crisis is on the rise, and now corporate shareholders are entering the fray. In recent months, shareholders have brought a number of lawsuits...

Read More

Insurance Coverage & Recovery

Tide Turns on Phantom Exclusion

“Final adjudication” undermines the insurance industry’s disgorgement defense.

For decades, the protection provided by directors and officers (D&O) and errors and omissions (E&O) professional liability insurance policies has been weakened by insurance companies...

Read More

Automotive | Technology

Fast Take: As Autonomous Vehicles Hit the Road, Big Data Gets Even Bigger

While industry players face various liability and competition issues in the race for connected cars and autonomous vehicles, big data presents the biggest challenge and opportunity. With connected cars moving toward tailored log-ins for each user and autonomous vehicles creating almost 1 gigabyte...

Read More